市場調查報告書
商品編碼
1190263
橘皮組織治療市場-增長、趨勢、COVID-19 影響和預測 (2023-2028)Cellulite Treatment Market - Growth, Trends, and Forecasts (2023 - 2028) |
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
脂肪團治療市場預計在未來五年內以 7.9% 的複合年增長率增長。
COVID-19 大流行對市場增長產生了強烈影響。 這主要是由於大流行期間脂肪團治療程序的減少。 例如,根據美國整形外科學會 2020 年發布的數據,2020 年有 86,350 次脂肪團治療程序,而 2019 年有 112,975 次脂肪團治療程序。 在大流行期間,橘皮組織治療程序下降了 24%,在大流行期間對市場產生了負面影響。 然而,大流行後嚴格的封鎖限制的放鬆使得診所和醫院得以重新開放,增加了患者的湧入。 預計這將有助於未來幾年的市場增長。
主要的市場增長因素是久坐不動的生活方式的增加、導致脂肪團形成的飲食失調以及肥胖人口的增加。 肥胖流行現在被認為是最重要的公共衛生問題之一。 根據 C3 機構 2021 年 7 月的新聞稿,肥胖已成為法國人的主要關注點,在過去 25 年中法國的肥胖率翻了一番。 此外,健康改善與差異辦公室於 2022 年 7 月更新的數據顯示,在 2020 年 11 月至 2021 年 11 月期間,英國 25.3% 的 18 歲及以上成年人將患有肥胖症。據說確實存在。 預計這種肥胖爆發將推動市場增長。
此外,橘皮組織治療技術的創新推出、宣傳活動和產品批准有望促進市場增長。 例如,2022 年 8 月,AirScult Technologies Inc. 推出了 AirSculpt Smooth,這是一種微創、單次治療的脂肪團去除技術。 同樣,2021 年 7 月,Endo International PLC 推出了“Really Cellulite”,旨在消除與脂肪團相關的錯誤信息。
生活習慣的增加最終將導致對橘皮組織治療的需求增加。 此外,脂肪團的形成影響個體的心理、行為和心理特徵。 因此,上述因素預計將在預測期內推動市場增長。
近年來,僵硬的橘皮組織佔據了市場主導地位。 由於患者和醫生的偏好,皮膚科診所和醫院的高需求預計將在預測期內主導市場。 推動脂肪團治療增長的主要因素之一是肥胖人群的增加。 此外,脂肪沉積的病例也在增加。
根據 2021 年 3 月發表的 NCBI 文章,固體或硬脂肪團在年輕女孩中更為常見,通常出現在臀部和大腿上部周圍。 該報告指出,中胚層療法是最好的治療方法之一,涉及將維生素、藥物和天然成分的定制組合注入在表面下起作用的中胚層。我來了。 肥胖病例的增加已經引起人們對治療脂肪團的整容手術的認識,擴大了市場上此類手術的範圍。
預計在預測期內,不同治療方式的可用性也將有助於該細分市場的增長。 例如,由 Macom 發布的數據指出,一些整容外科醫生推薦使用 Selfina 等基於切除的治療方法來治療緊湊型脂肪團。 Biotypsa 還使用脂肪空化技術提供密集的脂肪團減少和建模結果,以減少硬脂肪團。
因此,各種先進治療程序的可用性和硬脂肪團的流行預計將在預測期內促進該細分市場的增長。
北美已成為橘皮組織治療的主要市場,原因是久坐不動的生活方式導致肥胖症越來越普遍,並且該地區越來越多地採用先進技術。 近年來,已經從外科手術轉向非侵入性治療。 根據 Trust for Americas Health 於 2022 年 9 月發表的一篇文章,美國有 19 個州的肥胖率超過 35%。 預計美國的這種肥胖發生率將推動所研究市場的增長。
報告顯示,每 10 個美國成年人中就有 4 個肥胖,而且全國范圍內的肥胖率還在持續上升。 預計美國人口中肥胖症的增加將推動對橘皮組織治療的需求。
美國疾病控制與預防中心2021年5月發表的一篇文章提到,2020年美國有3,664,292人登記出生。 出生率和懷孕的這種增加預計將推動對脂肪團治療的需求,並有助於市場的增長。
美國產品批准數量的增加預計也將有助於所研究市場的增長。 例如,2021 年 2 月,美國食品和藥物管理局批准了 Soliton Inc. 的快速聲脈衝技術,以在短期內改善橘皮組織的外觀。
因此,預計上述因素等因素將在預測期內推動市場增長。
脂肪團治療市場競爭適中,由幾家主要參與者組成。 就市場收入份額而言,一些主要參與者目前主導著市場。 一些著名的參與者正在推出新產品,而另一些則正在分銷他們的產品。 市場壟斷企業包括 Merz Pharma GmbH & Co. KGaA、Cutera Inc.、Hologic Inc.、Candela Corporation 和 Inceler Medikal。
The cellulite treatment market is anticipated to witness a CAGR of 7.9% during the next five years.
The COVID-19 pandemic had a strong impact on the growth of the market. This was mainly due to the reduction of cellulite treatment procedures during the pandemic. For instance, as per the data published by the American Society of Plastic Surgeons in 2020, cellulite treatment procedures in 2020 were 86,350 compared to 2019, which had 112,975 cellular treatment procedures. There was a 24% reduction in cellulite treatment procedures during the pandemic, impacting the market negatively during the pandemic. However, the relaxation of strict lockdown regulations in the post-pandemic period led to the reopening of clinics and hospitals and a rise in patient inflow. This is expected to contribute to the growth of the market in the coming years.
The major market growth factors are a rise in the sedentary lifestyle, poor dietary habits resulting in cellulite formation, and an increasing obesity population. The prevalence of obesity is now considered one of the most important public health problems. As per a press release in July 2021 by the C3 organization, obesity has become a major concern among the French population, and it has doubled in France over the last 25 years. Additionally, according to the Office for Health Improvement and Disparities data updated in July 2022, from November 2020 to November 2021, 25.3% of adults aged 18 and above were living with obesity in England. Such an incidence of obesity is expected to drive the growth of the market.
Moreover, innovative launches, awareness campaigns, and product approvals of cellulite treatment technologies are expected to contribute to the growth of the market. For instance, in August 2022, AirScult Technologies Inc. launched AirSculpt Smooth, a cellulite removal technology that is a minimally-invasive one-time procedure. Similarly, in July 2021, Endo International PLC launched "Really Cellulite", designed to eliminate the misinformation relating to cellulite.
The rising lifestyle-related habits would ultimately lead to an increase in demand for cellulite treatment. Furthermore, the formation of cellulite affects an individual's psychological, behavioral, and psychiatric characteristics. Hence, the above-mentioned factors are expected to drive the growth of the market during the forecast period.
The hard cellulite segment dominated the market in recent years. It is expected to dominate the market during the forecast period due to high demand from specialized dermatology clinics and hospitals, owing to the preference of the patients and physicians. One of the major drivers for the growth of cellulite treatment is the increasing number of obese people. There is also an increased number of cases of fat deposition.
According to an NCBI article published in March 2021, solid or hard cellulite is quite common in younger girls and is usually found around the hips and upper thighs. The report also mentioned that mesotherapy is one of the best treatments, which includes injecting customized combinations of vitamins, drugs, and natural takeouts into the mesoderm layer, which works under the surface. The increasing number of obesity cases created awareness among people regarding cosmetic procedures for the treatment of cellulite and broadened the scope of such surgeries in the market.
Also, the availability of various treatment procedures is expected to contribute to the growth of the segment over the forecast period. For instance, the data published by Macom mentioned that some cosmetic surgeons recommend excision-based treatments, such as Cellfina, to treat compact cellulite. Also, the company, Biotypsa uses Fat Cavitation technology, which offers intensive fatty cellulite reduction and modeling results for reducing hard cellulite.
Thus, the availability of various advanced treatment procedures and the prevalence of hard cellulite are expected to contribute to the growth of the segment over the forecast period.
North America is the primary market for cellulite treatment, owing to the rise in the number of obesity cases due to a sedentary lifestyle and an increase in the adoption of advanced technologies in the region. A shift from surgical procedures toward non-invasive treatments has increased in recent years. As per the article published by the Trust for America's Health in September 2022, 19 states in United States have obesity rates over 35%. Such an incidence of obesity in United States is expected to drive the growth of the market studied.
According to the same report, four in ten American adults have obesity, and obesity rates continue to increase nationwide. Such an increase in obesity among the US population is expected to drive the demand for cellulite treatment.
An article published by the Centers for Disease Control and Prevention in May 2021 mentioned that the registered number of births in United States in 2020 was 3,664,292. Such an increase in birth rates and pregnancy is expected to drive the demand for cellulite treatment, thereby contributing to the growth of the market.
Also, the increasing product approvals in United States are expected to contribute to the growth of the market studied. For instance, in February 2021, United States Food and Drug Administration approved the Rapid Acoustic pulse technology by Soliton Inc. for short-term improvement in the appearance of cellulite.
Thus, the above-mentioned factors are expected to drive the growth of the market during the forecast period.
The cellulite treatment market is moderately competitive and consists of several major players. In terms of market revenue share, a few key players are currently dominating the market. Some prominent players are launching new products, while others are distributing the products. Some of the companies dominating the market are Merz Pharma GmbH & Co. KGaA, Cutera Inc., Hologic Inc., Candela Corporation, and Inceler Medikal Co. Ltd.